(Q45844531)

16 December 2017

title

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis (English)

1 reference

16 December 2017

0 references

0 references

1 reference

1 reference

hepatocellular carcinoma

1 reference

1 reference

1

1 reference

16 December 2017

Xavier Calvet

3

1 reference

16 December 2017

Xavier Calvet

4

1 reference

16 December 2017

author name string

J M Barrera

2

1 reference

16 December 2017

G Ercilla

5

1 reference

16 December 2017

J Costa

6

1 reference

16 December 2017

J M Sanchez-Tapias

7

1 reference

16 December 2017

M Ventura

8

1 reference

16 December 2017

M Vall

9

1 reference

16 December 2017

M Bruguera

10

1 reference

16 December 2017

C Bru

11

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 October 1989

1 reference

16 December 2017

published in

The Lancet

1 reference

16 December 2017

volume

2

1 reference

16 December 2017

issue

8670

1 reference

16 December 2017

page(s)

1004-1006

1 reference

16 December 2017

A case-control study of primary hepatocellular carcinoma in Taiwan

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991015-5

7 January 2021

Cirrhosis and the aetiology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991015-5

7 January 2021

Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991015-5

7 January 2021

Primary liver cancer. Quadrennial review lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991015-5

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991015-5

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991015-5

7 January 2021

Hepatitis C virus antibodies among risk groups in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991015-5

7 January 2021

Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991015-5

7 January 2021

Hepatitis B virus, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991015-5

7 January 2021

Primary liver cancer in Côte d'Or (France).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991015-5

7 January 2021

Hepatitis B virus (HBV) and hepatocellular carcinoma. HBV DNA status and its implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991015-5

7 January 2021

Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2991015-5

7 January 2021

10.1016/S0140-6736(89)91015-5

Identifiers

DOI

1 reference

16 December 2017

1 reference

16 December 2017